Cho BC - Search Results

1

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial.

Paz-Ares L, Kim TM, Vicente D, Felip E, Lee DH, Lee KH, Lin CC, Flor MJ, Di Nicola M, Alvarez RM, Dussault I, Helwig C, Ojalvo LS, Gulley JL, Cho BC. Paz-Ares L, et al. Among authors: cho bc. J Thorac Oncol. 2020 Jul;15(7):1210-1222. doi: 10.1016/j.jtho.2020.03.003. Epub 2020 Mar 13. J Thorac Oncol. 2020. PMID: 32173464 Free PMC article. Clinical Trial.

2

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.

Sohn JH, Choi HJ, Chang J, Kim SK, Lee CG, Chung KY, Kim DJ, Cho BC, Shin SJ, Moon YW, Kim JH. Sohn JH, et al. Among authors: cho bc. Lung Cancer. 2006 Dec;54(3):365-70. doi: 10.1016/j.lungcan.2006.08.014. Epub 2006 Sep 29. Lung Cancer. 2006. PMID: 17011068 Clinical Trial.

3

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ, Sohn JH, Kim H, Kim JH. Cho BC, et al. J Clin Oncol. 2007 Jun 20;25(18):2528-33. doi: 10.1200/JCO.2006.10.4166. J Clin Oncol. 2007. PMID: 17577030 Clinical Trial.

4

The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.

Kim SH, Cho BC, Choi HJ, Chung KY, Kim DJ, Park MS, Kim SK, Chang J, Shin SJ, Sohn JH, Kim JH. Kim SH, et al. Among authors: cho bc. Lung Cancer. 2008 Jun;60(3):393-400. doi: 10.1016/j.lungcan.2007.11.004. Epub 2007 Dec 26. Lung Cancer. 2008. PMID: 18155802

5

High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.

Lee YJ, Cho A, Cho BC, Yun M, Kim SK, Chang J, Moon JW, Park IK, Choi HJ, Kim JH. Lee YJ, et al. Among authors: cho bc, cho a. Clin Cancer Res. 2009 Apr 1;15(7):2426-32. doi: 10.1158/1078-0432.CCR-08-2258. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318478

6

Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

Lee YJ, Park IK, Park MS, Choi HJ, Cho BC, Chung KY, Kim SK, Chang J, Moon JW, Kim H, Choi SH, Kim JH. Lee YJ, et al. Among authors: cho bc. J Cancer Res Clin Oncol. 2009 Dec;135(12):1647-54. doi: 10.1007/s00432-009-0611-7. Epub 2009 Jun 11. J Cancer Res Clin Oncol. 2009. PMID: 19517135

7

Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.

Lee YJ, Choi HJ, Kim SK, Chang J, Moon JW, Park IK, Kim JH, Cho BC. Lee YJ, et al. Among authors: cho bc. Cancer. 2010 Mar 1;116(5):1336-43. doi: 10.1002/cncr.24877. Cancer. 2010. PMID: 20066717 Free article.

8

Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial.

Jeong J, Cho BC, Sohn JH, Choi HJ, Kim SH, Lee YJ, Jung MK, Shin SJ, Park MS, Kim SK, Chang J, Kim JH. Jeong J, et al. Among authors: cho bc. Lung Cancer. 2010 Oct;70(1):77-81. doi: 10.1016/j.lungcan.2010.01.006. Epub 2010 Mar 16. Lung Cancer. 2010. PMID: 20138389 Clinical Trial.

9

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.

Kim HR, Shim HS, Chung JH, Lee YJ, Hong YK, Rha SY, Kim SH, Ha SJ, Kim SK, Chung KY, Soo R, Kim JH, Cho BC. Kim HR, et al. Among authors: cho bc. Cancer. 2012 Feb 1;118(3):729-39. doi: 10.1002/cncr.26311. Epub 2011 Jun 30. Cancer. 2012. PMID: 21720997 Free article.

10

Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients.

Kim GM, Kim YS, Ae Kang Y, Jeong JH, Kim SM, Hong YK, Sung JH, Lim ST, Kim JH, Kim SK, Cho BC. Kim GM, et al. Among authors: cho bc. J Thorac Oncol. 2012 Apr;7(4):731-6. doi: 10.1097/JTO.0b013e31824b23cb. J Thorac Oncol. 2012. PMID: 22425922 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

763 results

Search Page

Filters